Searched for
BAYER SCHERING PHARMA
Cipla shocks rivals by slashing cancer drug prices up to 75%Kidney cancer drug will now be available at Rs 6,840 for a month's supply, down from Rs 28,000. Lung cancer drug will cost Rs 4,250, down f...- Zydus Cadila Q1 net up 15.38% at Rs 229.82 croreAhmedabad-based Zydus Cadila today said its consolidated net profit rose by 15.38 per cent to Rs 229.82 crore in the first quarter ended Ju...
- Non-compliance with disclosure norms on patents may bring trouble for pharma companiesSeveral global drugmakers, including Pfizer, Roche and Bayer, have not met full mandatory disclosures of their patented medicines in India,...
- Zydus Cadila in talks to market Bayer drugsAhmedabad-based drugmaker Zydus Cadila is in talks with Bayer Schering Pharma AG to market the German firm’s products in Indian retail mark...
- Biocon in talks with Bayer for drug developmentTwo pharma cos may sign pact involving co-development of new biotech drugs & research services.
- Pharma action hots up: UCB acquires Schwarz for $5.6bnUCB, the Belgian maker of the allergy drug Zyrtec, agreed to buy Schwarz Pharma for E4.4bn ($5.6bn) in cash and stock to gain new medicines...
- Merck to acquire biotech firm Serono for $13.3 bnGerman drugmaker Merck unveiled a surprise 16.6-bn-Swiss franc ($13.3 bn) deal to buy Swiss biotech firm Serono on Thursday, creating a new...
- Bayer group to sell diagnostics biz to SiemensMultinational healthcare and pharmaceutical major Bayer Group on Friday said it is planning to sell its diagnostics business to Siemens AG,...
Load More- Zydus Cadila in talks to market Bayer drugs